Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Orchestra BioMed Holdings, Inc. | General Manager and Senior Vice President, Focal Therapies | Common Stock, par value $0.0001 per share ("Common Stock") | 42K | $21.6K | $1.08 | May 8, 2024 | Direct |
Orchestra BioMed Holdings, Inc. | General Manager and Senior Vice President, Focal Therapies | Stock Option (Right to Buy) | 33K | May 8, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OBIO | Orchestra BioMed Holdings, Inc. | May 8, 2024 | 2 | $0 | 4 | May 10, 2024 | General Manager and Senior Vice President, Focal Therapies |
OBIO | Orchestra BioMed Holdings, Inc. | Sep 19, 2023 | 0 | $0 | 3 | Sep 29, 2023 | Title: General Manager and Senior Vice President, Focal Therapies Exhibit 24 - Power of Attorney |